These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36495008)

  • 1. Angiotensin-converting enzyme 2 in human plasma and lung tissue.
    Xie J; Huang QF; Zhang Z; Dong Y; Xu H; Cao Y; Sheng CS; Li Y; Wang C; Wang X; Wang JG
    Blood Press; 2023 Dec; 32(1):6-15. PubMed ID: 36495008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney.
    Jiang X; Eales JM; Scannali D; Nazgiewicz A; Prestes P; Maier M; Denniff M; Xu X; Saluja S; Cano-Gamez E; Wystrychowski W; Szulinska M; Antczak A; Byars S; Skrypnik D; Glyda M; Król R; Zywiec J; Zukowska-Szczechowska E; Burrell LM; Woolf AS; Greenstein A; Bogdanski P; Keavney B; Morris AP; Heagerty A; Williams B; Harrap SB; Trynka G; Samani NJ; Guzik TJ; Charchar FJ; Tomaszewski M
    Eur Heart J; 2020 Dec; 41(48):4580-4588. PubMed ID: 33206176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors.
    Sama IE; Ravera A; Santema BT; van Goor H; Ter Maaten JM; Cleland JGF; Rienstra M; Friedrich AW; Samani NJ; Ng LL; Dickstein K; Lang CC; Filippatos G; Anker SD; Ponikowski P; Metra M; van Veldhuisen DJ; Voors AA
    Eur Heart J; 2020 May; 41(19):1810-1817. PubMed ID: 32388565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: Understanding the impact of anti-hypertensive drugs and hydroxychloroquine on the ACE1 and ACE2 in lung and adipose tissue in SHR and WKY rats.
    Corrêa BSG; de Barros S; Vaz JB; Peres MA; Uchiyama MK; da Silva AA; Furukawa LNS
    Physiol Rep; 2023 Feb; 11(3):e15598. PubMed ID: 36750199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity.
    Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F
    Rev Port Cardiol; 2023 Apr; 42(4):373-383. PubMed ID: 36893838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Complexes of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Receptors: Expression in Adult but Not Fetal Lung Tissue.
    Franco R; Lillo A; Rivas-Santisteban R; Rodríguez-Pérez AI; Reyes-Resina I; Labandeira-García JL; Navarro G
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19.
    Malek Mahdavi A
    Rev Med Virol; 2020 Sep; 30(5):e2119. PubMed ID: 32584474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19.
    Silva MG; Corradi GR; Pérez Duhalde JI; Nuñez M; Cela EM; Gonzales Maglio DH; Brizzio A; Salazar MR; Espeche WG; Gironacci MM
    Biomed Pharmacother; 2022 Aug; 152():113201. PubMed ID: 35661534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The renin-angiotensin system in COVID-19: Why ACE2 targeting by coronaviruses produces higher mortality in elderly hypertensive patients?
    Kurbel S
    Bioessays; 2021 Mar; 43(3):e2000112. PubMed ID: 33336824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The systemic renin-angiotensin system in COVID-19.
    Reindl-Schwaighofer R; Hödlmoser S; Domenig O; Krenn K; Eskandary F; Krenn S; Schörgenhofer C; Rumpf B; Karolyi M; Traugott MT; Abrahamowicz A; Tinhof V; Mayfurth H; Rathkolb V; Mußnig S; Schmölz L; Ullrich R; Heinzel A; König F; Binder C; Bonderman D; Strassl R; Puchhammer-Stöckl E; Gorkiewicz G; Aberle JH; Jilma B; Wenisch C; Poglitsch M; Oberbauer R; Zoufaly A; Hecking M
    Sci Rep; 2022 Nov; 12(1):20117. PubMed ID: 36418458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of renin-angiotensin-aldosterone system inhibitors on COVID-19.
    Matsuzawa Y; Kimura K; Ogawa H; Tamura K
    Hypertens Res; 2022 Jul; 45(7):1147-1153. PubMed ID: 35581498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences.
    Dettlaff-Pokora A; Swierczynski J
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of angiotensin-converting enzyme 2 by renin-angiotensin system inhibitors. Truth or myth? A systematic review of animal studies.
    Kai H; Kai M; Niiyama H; Okina N; Sasaki M; Maeda T; Katoh A
    Hypertens Res; 2021 Aug; 44(8):955-968. PubMed ID: 33750913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.